Poseida Therapeutics, Inc., Expands Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- S&P 500, Nasdaq set for lower open as chip weakness weighs
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil rises over 1% as Iran threat puts Red Sea route at risk
- Citi sees Google, Meta and Amazon capex spending at over $800 billion in 2027
- UnitedHealth shares surge on strong earnings beat and guidance
Amarin Corp plc (AMRN) Misses Q2 EPS by 3c
August 6, 2015 4:05 PM EDTAmarin Corp plc (NASDAQ: AMRN) reported Q2 EPS of ($0.15), $0.03 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $17.7 million versus the consensus estimate of $19.1 million.
For earnings history and earnings-related data on Amarin Corp plc (AMRN) click here.
... More